Wolverine Trading’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$139K	Buy	52,700 +27,500	+109%	+$53.2K	﹤0.01%	5088
2025 Q2	$25K	Buy	25,200 +300	+1%	+$300	﹤0.01%	4453
2025 Q1	$37.4K	Sell	24,900 -5,100	-17%	-$9.4K	﹤0.01%	4481
2024 Q4	$64.5K	Buy	30,000 +11,500	+62%	+$26.8K	﹤0.01%	4920
2024 Q3	$31.1K	Sell	18,500 -10,200	-36%	-$20.6K	﹤0.01%	4594
2024 Q2	$63.7K	Buy	+28,700	New	+$67.5K	﹤0.01%	4179
2023 Q4	–	Sell	-14,800	Closed	-$14.5K	–	4669
2023 Q3	$14.5K	Buy	14,800 +4,000	+37%	+$5.79K	﹤0.01%	4353
2023 Q2	$14.5K	Sell	10,800 -1,700	-14%	-$2.37K	﹤0.01%	4116
2023 Q1	$21K	Sell	12,500 -34,600	-73%	-$179K	﹤0.01%	3994
2022 Q4	$293K	Buy	+47,100	New	+$337K	﹤0.01%	2779
2021 Q4	–	Sell	-25,600	Closed	-$318K	–	6140
2021 Q3	$318K	Buy	+25,600	New	+$373K	﹤0.01%	4617
2021 Q2	–	Sell	-19,200	Closed	-$527K	–	6194
2021 Q1	$527K	Buy	+19,200	New	+$566K	﹤0.01%	3625
2020 Q2	–	Sell	-13,400	Closed	-$455K	–	4731
2020 Q1	$455K	Sell	13,400 -19,100	-59%	-$1.01M	﹤0.01%	2763
2019 Q4	$1.94M	Buy	32,500 +5,300	+19%	+$238K	﹤0.01%	1857
2019 Q3	$1.03M	Buy	27,200 +10,800	+66%	+$428K	﹤0.01%	1961
2019 Q2	$763K	Buy	16,400 +1,800	+12%	+$84.5K	﹤0.01%	2289
2019 Q1	$586K	Sell	14,600 -5,800	-28%	-$260K	﹤0.01%	2589
2018 Q4	$901K	Buy	+20,400	New	+$983K	﹤0.01%	2064
2018 Q3	–	Sell	-42,100	Closed	-$3.04M	–	5154
2018 Q2	$3.04M	Hold	42,100	–	–	0.01%	1241
2018 Q1	$3.04M	Buy	42,100 +9,400	+29%	+$690K	0.01%	1241
2017 Q4	$2.15M	Buy	32,700 +2,500	+8%	+$135K	0.01%	1487
2017 Q3	$1.51M	Sell	30,200 -8,500	-22%	-$410K	0.01%	1537
2017 Q2	$1.83M	Buy	+38,700	New	+$1.42M	0.01%	1292